These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8697492)

  • 21. A comparison of the effect of feeding a low-protein diet and of pharmacological intervention on the course of ablation nephropathy in the rat.
    Cervenka L; Heller J
    Ren Fail; 1995 Jan; 17(1):27-35. PubMed ID: 7770641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enalapril improves glucose tolerance in two rat models: a new hypertensive diabetic strain and a fructose-induced hyperinsulinaemic rat.
    Rosenthal T; Erlich Y; Rosenmann E; Grossman E; Cohen A
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S353-4. PubMed ID: 9072425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of enalapril and sairei-to on survival-time for the rat with subtotal nephrectomy.
    Satoh S; Kaneko T; Omori S; Sugimura J; Ujiie T; Fujioka T; Kubo T
    Nihon Jinzo Gakkai Shi; 1995 Feb; 37(2):112-8. PubMed ID: 7752502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the effects of angiotensin converting enzyme inhibitors with or without a thiol group in chronic renal failure in rats.
    Ohishi A; Suzuki H; Nakamoto H; Katsumata H; Sakaguchi H; Saruta T
    Clin Sci (Lond); 1989 Apr; 76(4):353-6. PubMed ID: 2540931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic effects of FR139317 and enalapril on renal failure rats with moderate exercise.
    Kohzuki M; Kamimoto M; Wu XM; Yoshida K; Saito T; Sato T
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S486-8. PubMed ID: 9595520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits in nutritional interventions in patients with CKD stage 3-4.
    Chauveau P; Aparicio M
    J Ren Nutr; 2011 Jan; 21(1):20-2. PubMed ID: 21195912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-protein diet and progression of chronic renal failure.
    Nonoguchi H; Kiyama S; Naruse M; Tomita K
    Lancet; 1997 Jul; 350(9071):146. PubMed ID: 9228989
    [No Abstract]   [Full Text] [Related]  

  • 28. Benefit of moderate dietary protein restriction on growth in the young animal with experimental chronic renal insufficiency: importance of early growth.
    Friedman AL; Pityer R
    Pediatr Res; 1989 May; 25(5):509-13. PubMed ID: 2717267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary protein restriction in combination with angiotensin converting enzyme inhibitor improves insulin resistance in patients with chronic renal disease.
    Stefíková K; Spustová V; Gazdíková K; Krivosíková Z; Dzúrik R
    Int Urol Nephrol; 1997; 29(4):497-507. PubMed ID: 9406010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical practice. Nondiabetic kidney disease.
    Levey AS
    N Engl J Med; 2002 Nov; 347(19):1505-11. PubMed ID: 12421894
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal effect of anti-hypertensive drugs depends on sodium diet in the excision remnant kidney model.
    Terzi F; Beaufils H; Laouari D; Burtin M; Kleinknecht C
    Kidney Int; 1992 Aug; 42(2):354-63. PubMed ID: 1405318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and treatment of kidney failure].
    Hishida A
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():127-31. PubMed ID: 11989251
    [No Abstract]   [Full Text] [Related]  

  • 33. End-stage renal disease. Measures to prevent it or slow its progression.
    Hood VL; Gennari FJ
    Postgrad Med; 1996 Nov; 100(5):163-6, 171-6. PubMed ID: 8917331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease.
    Gansevoort RT; de Zeeuw D; de Jong PE
    Nephrol Dial Transplant; 1995; 10(4):497-504. PubMed ID: 7623991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of efficacy of angiotensin-converting enzyme inhibitors in reducing interdialytic weight gain.
    Bastani B; Redington J
    Am J Kidney Dis; 1994 Dec; 24(6):907-11. PubMed ID: 7985667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Etiology and therapy of chronic primary glomerulonephritis].
    Dohi K; Kanauchi M
    Nihon Naika Gakkai Zasshi; 1998 Jul; 87(7):1271-6. PubMed ID: 9745275
    [No Abstract]   [Full Text] [Related]  

  • 37. Blood pressure and angiotensin converting enzyme inhibitor use in hypertensive patients with chronic renal insufficiency.
    Ramirez LM
    Am J Hypertens; 2002 Sep; 15(9):832-3. PubMed ID: 12219882
    [No Abstract]   [Full Text] [Related]  

  • 38. Associated effect of hepatic hydroxymethylglutaryl coenzyme A reductase + angiotensin converting enzyme inhibitors on the progression of renal failure in hypertensive subjects.
    Scanferla F; Toffoletto PP; Roncali D; Bazzato G
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):868. PubMed ID: 1747221
    [No Abstract]   [Full Text] [Related]  

  • 39. [Abnormalities of protein metabolism during chronic renal insufficiency (CRI). Diet therapy trials].
    Nebout T; Lagrue G
    Sem Hop Ther; 1977 Apr; 53(4):237-9. PubMed ID: 882868
    [No Abstract]   [Full Text] [Related]  

  • 40. Synergetic effect of low protein diet combined with oral adsorbent on the progression of chronic renal failure.
    Takahashi S; Okada K; Shibahara H; Higuchi T
    Nephron; 1996; 72(3):490-1. PubMed ID: 8852506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.